Psoriatic Arthritis Treatment Market, By Drug Class (Biologics, Non-biologics, Combination Therapy), By Product Type (Prescription and Over The Counter (OTC)), By Route of Administration (Parenteral and Oral), By Distribution Channel (Hospital Pharmacies,

Psoriatic Arthritis Treatment Market, By Drug Class (Biologics, Non-biologics, Combination Therapy), By Product Type (Prescription and Over The Counter (OTC)), By Route of Administration (Parenteral and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)


Psoriatic arthritis is a chronic inflammatory arthritis that occurs in conjunction with psoriasis. It is estimated that around 30% of people with psoriasis may develop psoriatic arthritis. The disease causes pain, stiffness and swelling in and around the joints. Over time, psoriatic arthritis can cause permanent damage to the joints. Conventional treatments including disease-modifying antirheumatic drugs (DMARDs) such as methotrexate and TNF inhibitors are used to manage the symptoms. Global psoriatic arthritis treatment market growth is driven by rising development and approval of novel targeted biologic therapies with better safety and efficacy profiles.

Market Dynamics:

Global psoriatic arthritis treatment market growth is driven by growing prevalence of psoriatic arthritis worldwide. According to estimates, the global prevalence of the disease ranges between 0.06% to 1%. Moreover, increasing awareness about the disease and availability of advanced treatments can also drive the market growth. However, high cost of biologic therapies can hamper the market growth, especially in price-sensitive developing regions. Continued efforts by market players to develop cost-effective generic versions of biologics can reduce costs over time. Furthermore, rising healthcare expenditures in emerging nations can offer new opportunities for the market players in the near future.

Key features of the study:
  • This report provides in-depth analysis of the global psoriatic arthritis treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global psoriatic arthritis treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Pfizer, Johnson & Johnson, AbbVie, Novartis, UCB, Eli Lilly, Bristol-Myers Squibb
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global psoriatic arthritis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global psoriatic arthritis treatment market
Detailed Segmentation-
  • Drug Class Insights (Revenue, USD Bn, 2019 - 2031)
  • Biologics
  • Non-biologics
  • Combination Therapy
  • Product Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Prescription
  • Over-The-Counter (OTC)
  • Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
  • Parenteral
  • Oral
  • Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Medtronic
  • Johnson & Johnson (DePuy Synthes)
  • Zimmer Biomet
  • Stryker
  • Xtant Medical
  • RTI Surgical
  • SeaSpine
  • Arthrex
  • HansBioMed
  • Exactech
  • Wright Medical Group
  • Bioventus
  • Integra LifeSciences
  • AlloSource
  • Medline Industries
  • Osiris Therapeutics
  • Acelity
  • Orthofix
  • MTF Biologics
  • Cerapedics


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Deployment
Market Snapshot, By Application
Market Snapshot, By End User
Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter’s Analysis
4. Global Collaborative Care Model Market- Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the Market
5. Global Collaborative Care Model Market, By Deployment, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Web-based
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Cloud-based
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn) Myoglobin
On-premise
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
6. Global Collaborative Care Model Market, By Application, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Population-based Care
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Patient-centered Team Care
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Measurement-based Treatment
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Evidence-based Care
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Accountable Care
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
7. Global Collaborative Care Model Market, By End User, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Hospitals and Clinics
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Ambulatory Care Centers
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Rehabilitation Centers
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Academic & Research Institute
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
8. Global Collaborative Care Model Market, By Region, 2019 – 2031, (USDBn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2020–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Deployment, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Deployment, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Deployment, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Deployment, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Deployment, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Deployment, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Company Profiles
Kaiser Permanente
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Geisinger Health System
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Intermountain Healthcare
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Mayo Clinic
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Cleveland Clinic
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Partners HealthCare
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Baylor Scott & White Health
University of Washington Medicine
Mount Sinai Health System
HealthPartners
Providence Health & Services
Ascension Health
Dartmouth-Hitchcock Health
Scripps Health
Northwell Health
UnityPoint Health
WellSpan Health
Blue Cross Blue Shield Association
10. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
11. Research Methodology
References
Research Methodology
About us and Sales Contact
*Browse 32 market data tables and 28 figures on Collaborative Care Model Market” -Global forecast to 2031

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings